Home
Search 
BLAST
Manual
DownloadDetails of Virus RNA
| Strain Information | Strain Name |
Poliovirus
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Strain Family |
Picornaviridae
|
||||||||
| RNA Binding Site |
5'UTR - 3'UTR
|
||||||||
| Virus Information | Virus Name |
Poliovirus (PV)
|
|||||||
| Taxonomy ID | 12637 | ||||||||
| GeneBank ID | KF907503 | ||||||||
Full list of proteins interacting with the 5'UTR - 3'UTR of this Strain
| Protein Name | Uniprot ID | Host Species | Pro Info | Detection Method | Infection Cell | Cell ID | Cell Originated Tissue | Infection Time | Interaction Score | Fold Change |
|---|---|---|---|---|---|---|---|---|---|---|
| A-kinase anchor protein 8 | O43823 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| ATP-dependent RNA helicase A | Q08211 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Bcl-2-associated transcription factor 1 | Q9NYF8 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Cold shock domain-containing protein E1 | O75534 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Cyclic AMP-responsive element-binding protein 1 | P16220 | Homo sapiens | Pro Info | Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting with anti-PCBP polyclonal anti serum | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 7 h | . | . |
| DBIRD complex subunit ZNF326 | Q5BKZ1 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Dystrophin | P11532 | Homo sapiens | Pro Info | Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting with anti-PCBP polyclonal anti serum | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 7 h | . | . |
| E1B-55 kDa-associated protein 5 | Q9BUJ2 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| eIF-4-gamma 1 | Q04637 | Homo sapiens | Pro Info | Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting with anti-PCBP polyclonal anti serum | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 7 h | . | . |
| eIF-4-gamma 3 | O43432 | Homo sapiens | Pro Info | Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting with anti-PCBP polyclonal anti serum | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 7 h | . | . |
| Eukaryotic initiation factor 4A-I | P60842 | Homo sapiens | Pro Info | Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting with anti-PCBP polyclonal anti serum | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 7 h | . | . |
| Far upstream element-binding protein 2 | Q92945 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| GAP-associated tyrosine phosphoprotein p62 | Q07666 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Helicase with 2 CARD domains | Q9BYX4 | Homo sapiens | Pro Info | . | B95a Cells (Marmoset lymphoblastoid cell line) | . | . | . | . | . |
| Heterogeneous nuclear ribonucleoprotein A0 | Q13151 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Heterogeneous nuclear ribonucleoprotein A3 | P51991 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Heterogeneous nuclear ribonucleoprotein D-like | O14979 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Heterogeneous nuclear ribonucleoprotein D0 | Q14103 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Heterogeneous nuclear ribonucleoprotein K | P61978 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Heterogeneous nuclear ribonucleoprotein L | P14866 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Heterogeneous nuclear ribonucleoprotein L-like | Q8WVV9 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Heterogeneous nuclear ribonucleoprotein Q | O60506 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Heterogeneous nuclear ribonucleoprotein R | O43390 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Heterogeneous nuclear ribonucleoprotein U | Q00839 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Heterogeneous nuclear ribonucleoproteins C1/C2 | P07910 | Homo sapiens | Pro Info | UV cross-linking (UVX) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Heterogeneous nuclear ribonucleoproteins C1/C2 | P07910 | Homo sapiens | Pro Info | UV cross-linking (UVX) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Heterogeneous nuclear ribonucleoproteins C1/C2 | P07910 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Histone H2B type 1-D | P58876 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Importin subunit alpha-1 | P52292 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Interleukin enhancer-binding factor 2 | Q12905 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Interleukin enhancer-binding factor 3 | Q12906 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| La-related protein 1 | Q6PKG0 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Lupus La protein | P05455 | Homo sapiens | Pro Info | Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting with anti-PCBP polyclonal anti serum | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 7 h | . | . |
| Lupus La protein | P05455 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Microtubule-associated protein 4 | P27816 | Homo sapiens | Pro Info | Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting with anti-PCBP polyclonal anti serum | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 7 h | . | . |
| Myb-binding protein 1A | Q9BQG0 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| NonO protein | Q15233 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Nucleolar protein 1 | P46087 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Nucleolar RNA helicase 2 | Q9NR30 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Nucleolin | P19338 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Nucleolysin TIA-1 isoform p40 | P31483 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Nucleolysin TIAR | Q01085 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| PAI1 RNA-binding protein 1 | Q8NC51 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Peptidyl-prolyl cis-trans isomerase A | P62937 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Poly(rC)-binding protein 1 | Q15365 | Homo sapiens | Pro Info | Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting with anti-PCBP polyclonal anti serum | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 7 h | . | . |
| Poly(rC)-binding protein 1 | Q15365 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Poly(rC)-binding protein 2 | Q15366 | Homo sapiens | Pro Info | Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting with anti-PCBP polyclonal anti serum | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 7 h | . | . |
| Poly(rC)-binding protein 2 | Q15366 | Homo sapiens | Pro Info | Electrophoretic mobility shift assay (EMSA) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Poly(rC)-binding protein 2 | Q15366 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Polyadenylate-binding protein 1 | P11940 | Homo sapiens | Pro Info | Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting with anti-PCBP polyclonal anti serum | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 7 h | . | . |
| Polyadenylate-binding protein 1 | P11940 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Polypyrimidine tract-binding protein 1 | P26599 | Homo sapiens | Pro Info | Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting with anti-PCBP polyclonal anti serum | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 7 h | . | . |
| Polypyrimidine tract-binding protein 1 | P26599 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Polypyrimidine tract-binding protein 1 | P26599 | Homo sapiens | Pro Info | UV cross-linking (UVX) | HeLa S3 Cells (Human cervical carcinoma cell) | . | Cervix | . | . | . |
| Polyubiquitin-B | P0CG47 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| POU domain | P14859 | Homo sapiens | Pro Info | Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting with anti-PCBP polyclonal anti serum | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 7 h | . | . |
| Probable ATP-dependent RNA helicase DDX17 | Q92841 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Probable ATP-dependent RNA helicase DDX5 | P17844 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Proliferation-associated protein 2G4 | Q9UQ80 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Protein FAM98A | Q8NCA5 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Ras GTPase-activating protein-binding protein 2 | Q9UN86 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Ribonucleases P/MRP protein subunit POP1 | Q99575 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Ribosomal L1 domain-containing protein 1 | O76021 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| RNA-binding motif protein | P38159 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| RNA-binding protein 28 | Q9NW13 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| RNA-binding protein 39 | Q14498 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| RNA-binding protein 4 | Q9BWF3 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| RNA-binding protein 47 | A0AV96 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| RNA-binding protein EWS | Q01844 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| RNA-binding protein FUS | P35637 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| RNA-binding protein FXR1 | P51114 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| RNA-binding protein FXR2 | P51116 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| RNA-binding protein Raly | Q9UKM9 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| rRNA 2'-O-methyltransferase fibrillarin | P22087 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| SAFB-like transcription modulator | Q9NWH9 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Scaffold-attachment factor A2 | Q1KMD3 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Serine/arginine-rich splicing factor 1 | Q07955 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Serine/arginine-rich splicing factor 10 | O75494 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Serine/arginine-rich splicing factor 2 | Q01130 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Serine/arginine-rich splicing factor 3 | P84103 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Serine/arginine-rich splicing factor 5 | Q13243 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Serine/arginine-rich splicing factor 6 | Q13247 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Serine/arginine-rich splicing factor 7 | Q16629 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Serine/arginine-rich splicing factor 9 | Q13242 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Splicing factor | P23246 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Splicing factor 3B subunit 4 | Q15427 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Splicing factor U2AF 65 kDa subunit | P26368 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| TATA-binding protein-associated factor 2N | Q92804 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| TATA-box-binding protein | P20226 | Homo sapiens | Pro Info | Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting with anti-PCBP polyclonal anti serum | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 7 h | . | . |
| Transcriptional activator protein Pur-alpha | Q00577 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Transformer-2 protein homolog beta | P62995 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Ubiquitin-associated protein 2-like | Q14157 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| X-ray repair cross-complementing protein 5 | P13010 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| X-ray repair cross-complementing protein 6 | P12956 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Y-box-binding protein 1 | P67809 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Zinc finger CCCH-type antiviral protein 1 | Q7Z2W4 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Zinc finger protein 638 | Q14966 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Zinc finger protein 9 | P62633 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
| Zinc finger RNA-binding protein | Q96KR1 | Homo sapiens | Pro Info | Thiouracil cross-linking mass spectrometry (TUX-MS) | HeLa Cells (Human cervical carcinoma cell) | . | Cervix | 5 h | . | . |
Functional Go Enrichment analysis of those proteins interacting with the 5'UTR - 3'UTR of this Strain
| GO Term | GO Category | GO ID | Adjusted P-value | Odds Ratio | Combined Score |
|---|---|---|---|---|---|
| RNA Binding | Molecular Function |
GO:0003723
|
8.68E-88 | 196.0527506 | 40239.05798 |
| mRNA Binding | Molecular Function |
GO:0003729
|
2.29E-43 | 56.03427031 | 5730.503074 |
| mRNA 3'-UTR Binding | Molecular Function |
GO:0003730
|
1.34E-21 | 60.77469358 | 3144.563174 |
| Single-Stranded RNA Binding | Molecular Function |
GO:0003727
|
1.03E-13 | 75.29166667 | 2507.193464 |
| pre-mRNA Binding | Molecular Function |
GO:0036002
|
1.58E-13 | 105.2328042 | 3435.376165 |
| Poly-Pyrimidine Tract Binding | Molecular Function |
GO:0008187
|
2.63E-10 | 93.2021419 | 2334.401902 |
| DNA Binding | Molecular Function |
GO:0003677
|
1.42E-08 | 6.601176064 | 137.9970921 |
| Double-Stranded RNA Binding | Molecular Function |
GO:0003725
|
2.47E-07 | 28.86663897 | 517.112978 |
| poly Binding | Molecular Function |
GO:0008143
|
1.08E-06 | 58.5 | 954.805852 |
| Poly-Purine Tract Binding | Molecular Function |
GO:0070717
|
3.04E-06 | 44.98642534 | 682.9021227 |
| Telomeric DNA Binding | Molecular Function |
GO:0042162
|
3.83E-06 | 41.76890756 | 620.3961591 |
| poly RNA Binding | Molecular Function |
GO:0008266
|
2.61E-05 | 51.4005168 | 660.3085935 |
| mRNA 3'-UTR AU-rich Region Binding | Molecular Function |
GO:0035925
|
2.91E-05 | 48.69277846 | 616.3884551 |
| mRNA 5'-UTR Binding | Molecular Function |
GO:0048027
|
3.23E-05 | 46.25581395 | 577.2651762 |
| Double-Stranded Telomeric DNA Binding | Molecular Function |
GO:0003691
|
3.85E-05 | 137.2758621 | 1679.650581 |
| Basal RNA Polymerase II Transcription Machinery Binding | Molecular Function |
GO:0001099
|
0.000150445 | 28.89244186 | 312.2825049 |
| Regulatory RNA Binding | Molecular Function |
GO:0061980
|
0.00026357 | 24.32313341 | 247.7822161 |
| Single-Stranded DNA Binding | Molecular Function |
GO:0003697
|
0.000482839 | 12.81124758 | 122.0217328 |
| RNA Cap Binding | Molecular Function |
GO:0000339
|
0.000507585 | 42.875 | 403.9052768 |
| miRNA Binding | Molecular Function |
GO:0035198
|
0.001760111 | 26.37135279 | 214.2875424 |
| Nucleus | Cellular Component |
GO:0005634
|
5.38E-28 | 13.11110317 | 880.0242076 |
| Intracellular Membrane-Bounded Organelle | Cellular Component |
GO:0043231
|
3.12E-24 | 10.84006352 | 626.1498496 |
| Cytoplasmic Stress Granule | Cellular Component |
GO:0010494
|
2.00E-14 | 47.70673077 | 1658.932537 |
| Nuclear Lumen | Cellular Component |
GO:0031981
|
8.19E-14 | 9.758023434 | 322.7766086 |
| Nucleolus | Cellular Component |
GO:0005730
|
4.91E-13 | 9.328465377 | 289.7750253 |
| Intracellular Non-Membrane-Bounded Organelle | Cellular Component |
GO:0043232
|
1.07E-10 | 6.512858212 | 166.0781689 |
| B-WICH Complex | Cellular Component |
GO:0110016
|
0.003223191 | 113.1022727 | 918.6400252 |
| Euchromatin | Cellular Component |
GO:0000791
|
0.009701469 | 16.71068124 | 115.0826143 |
| Filopodium | Cellular Component |
GO:0030175
|
0.019808181 | 12.01028433 | 71.93351933 |
| Endoribonuclease Complex | Cellular Component |
GO:1902555
|
0.019808181 | 30.14393939 | 179.3506662 |
| Chromosome | Cellular Component |
GO:0005694
|
0.041012351 | 5.74127907 | 28.95937667 |
| U12-type Spliceosomal Complex | Cellular Component |
GO:0005689
|
0.041012351 | 17.38111888 | 86.20454429 |
| Polysomal Ribosome | Cellular Component |
GO:0042788
|
0.041012351 | 17.38111888 | 86.20454429 |
| Secretory Granule Lumen | Cellular Component |
GO:0034774
|
0.076403972 | 3.707017212 | 15.80448459 |
| Cytoplasmic Vesicle Lumen | Cellular Component |
GO:0060205
|
0.076736866 | 6.09544335 | 25.54025005 |
| Ficolin-1-Rich Granule Lumen | Cellular Component |
GO:1904813
|
0.085948601 | 5.686781609 | 22.81622337 |
| Nuclear Stress Granule | Cellular Component |
GO:0097165
|
0.099696171 | 55.91573034 | 212.6557985 |
| Spliceosomal snRNP Complex | Cellular Component |
GO:0097525
|
0.114980675 | 8.204545455 | 29.56387179 |
| Ribosome | Cellular Component |
GO:0005840
|
0.118112874 | 7.646764253 | 26.59593512 |
| RISC-loading Complex | Cellular Component |
GO:0070578
|
0.118112874 | 37.27340824 | 129.3803096 |
| Regulation Of mRNA Splicing, Via Spliceosome | Biological Process |
GO:0048024
|
1.35E-33 | 103.0649351 | 8475.857027 |
| mRNA Splicing, Via Spliceosome | Biological Process |
GO:0000398
|
1.99E-26 | 40.78577337 | 2652.577054 |
| mRNA Processing | Biological Process |
GO:0006397
|
7.54E-25 | 37.74162679 | 2302.177146 |
| RNA Splicing, Via Transesterification Reactions With Bulged Adenosine As Nucleophile | Biological Process |
GO:0000377
|
1.45E-23 | 40.44527178 | 2335.769526 |
| RNA Processing | Biological Process |
GO:0006396
|
1.70E-23 | 39.68560468 | 2276.948956 |
| Regulation Of Alternative mRNA Splicing, Via Spliceosome | Biological Process |
GO:0000381
|
1.17E-21 | 104.5894737 | 5538.694392 |
| mRNA Stabilization | Biological Process |
GO:0048255
|
9.15E-18 | 83.86688312 | 3676.704166 |
| Regulation Of RNA Splicing | Biological Process |
GO:0043484
|
1.84E-15 | 41.49342105 | 1593.460438 |
| Positive Regulation Of Translation | Biological Process |
GO:0045727
|
3.76E-15 | 38.8331467 | 1458.945639 |
| mRNA Metabolic Process | Biological Process |
GO:0016071
|
5.01E-15 | 46.51767677 | 1729.370943 |
| Regulation Of Translation | Biological Process |
GO:0006417
|
4.57E-14 | 22.92821854 | 799.54299 |
| Negative Regulation Of mRNA Catabolic Process | Biological Process |
GO:1902373
|
1.19E-13 | 80.15725806 | 2711.647673 |
| Negative Regulation Of mRNA Splicing, Via Spliceosome | Biological Process |
GO:0048025
|
4.93E-12 | 239.7951807 | 7181.592131 |
| Positive Regulation Of Cytoplasmic Translation | Biological Process |
GO:2000767
|
4.93E-12 | 239.7951807 | 7181.592131 |
| Negative Regulation Of mRNA Processing | Biological Process |
GO:0050686
|
8.60E-12 | 209.810241 | 6152.448619 |
| Regulation Of mRNA Stability | Biological Process |
GO:0043488
|
5.06E-11 | 38.76171875 | 1065.425921 |
| Negative Regulation Of RNA Splicing | Biological Process |
GO:0033119
|
5.65E-11 | 139.8453815 | 3815.033805 |
| CRD-mediated mRNA Stabilization | Biological Process |
GO:0070934
|
5.65E-11 | 355.4642857 | 9689.658771 |
| Negative Regulation Of Translation | Biological Process |
GO:0017148
|
6.56E-11 | 28.73866034 | 777.5555097 |
| RNA Metabolic Process | Biological Process |
GO:0016070
|
9.38E-11 | 27.5835443 | 735.0213258 |
Functional KEGG Enrichment analysis of those proteins interacting with the 5'UTR - 3'UTR of this Strain
| Pathways | Category | Adjusted P-value | Odds Ratio | Combined Score |
|---|---|---|---|---|
| Spliceosome | KEGG Pathway | 8.95E-21 | 40.40436512 | 2039.608771 |
| RNA transport | KEGG Pathway | 7.30E-05 | 10.81501781 | 142.2117188 |
| Herpes simplex virus 1 infection | KEGG Pathway | 0.010122632 | 4.412860713 | 34.47263838 |
| Non-homologous end-joining | KEGG Pathway | 0.028357578 | 41.11363636 | 266.9942047 |
| Viral myocarditis | KEGG Pathway | 0.037580247 | 12.01028433 | 71.93351933 |
| Transcriptional misregulation in cancer | KEGG Pathway | 0.122117348 | 4.879267689 | 21.97001732 |
| Ribosome biogenesis in eukaryotes | KEGG Pathway | 0.122117348 | 6.50410509 | 28.34336567 |
| Viral carcinogenesis | KEGG Pathway | 0.122117348 | 4.606988431 | 19.88024767 |
| Ferroptosis | KEGG Pathway | 0.122117348 | 11.57983683 | 48.90207198 |
| Basal transcription factors | KEGG Pathway | 0.131161776 | 10.50052854 | 42.48752004 |
| Influenza A | KEGG Pathway | 0.290751023 | 4.027953479 | 12.70771314 |
| mRNA surveillance pathway | KEGG Pathway | 0.450739312 | 4.690814394 | 12.33425062 |
| Amyotrophic lateral sclerosis | KEGG Pathway | 0.472547616 | 2.525839793 | 6.320043977 |
| Systemic lupus erythematosus | KEGG Pathway | 0.638196597 | 3.379528366 | 7.064644533 |
| Circadian rhythm | KEGG Pathway | 0.638196597 | 7.445692884 | 15.15817559 |
| Hepatitis B | KEGG Pathway | 0.638196597 | 2.805397727 | 5.049165535 |
| Vasopressin-regulated water reabsorption | KEGG Pathway | 0.638196597 | 5.191272537 | 8.89703376 |
| Cocaine addiction | KEGG Pathway | 0.638196597 | 4.649344569 | 7.51796421 |
| Alcoholism | KEGG Pathway | 0.638196597 | 2.436511858 | 3.871464628 |
| Kaposi sarcoma-associated herpesvirus infection | KEGG Pathway | 0.638196597 | 2.346382675 | 3.599475253 |
Virus RNA Sequence Information
|
>NC_002058.3 Poliovirus, complete genome
TTAAAACAGCTCTGGGGTTGTACCCACCCCAGAGGCCCACGTGGCGGCTAGTACTCCGGTATTGCGGTAC
CCTTGTACGCCTGTTTTATACTCCCTTCCCGTAACTTAGACGCACAAAACCAAGTTCAATAGAAGGGGGT
ACAAACCAGTACCACCACGAACAAGCACTTCTGTTTCCCCGGTGATGTCGTATAGACTGCTTGCGTGGTT
GAAAGCGACGGATCCGTTATCCGCTTATGTACTTCGAGAAGCCCAGTACCACCTCGGAATCTTCGATGCG
TTGCGCTCAGCACTCAACCCCAGAGTGTAGCTTAGGCTGATGAGTCTGGACATCCCTCACCGGTGACGGT
GGTCCAGGCTGCGTTGGCGGCCTACCTATGGCTAACGCCATGGGACGCTAGTTGTGAACAAGGTGTGAAG
AGCCTATTGAGCTACATAAGAATCCTCCGGCCCCTGAATGCGGCTAATCCCAACCTCGGAGCAGGTGGTC
ACAAACCAGTGATTGGCCTGTCGTAACGCGCAAGTCCGTGGCGGAACCGACTACTTTGGGTGTCCGTGTT
TCCTTTTATTTTATTGTGGCTGCTTATGGTGACAATCACAGATTGTTATCATAAAGCGAATTGGATTGGC
CATCCGGTGAAAGTGAGACTCATTATCTATCTGTTTGCTGGATCCGCTCCATTGAGTGTGTTTACTCTAA
GTACAATTTCAACAGTTATTTCAATCAGACAATTGTATCATAATGGGTGCTCAGGTTTCATCACAGAAAG
TGGGCGCACATGAAAACTCAAATAGAGCGTATGGTGGTTCTACCATTAATTACACCACCATTAATTATTA
TAGAGATTCAGCTAGTAACGCGGCTTCGAAACAGGACTTCTCTCAAGACCCTTCCAAGTTCACCGAGCCC
ATCAAGGATGTCCTGATAAAAACAGCCCCAATGCTAAACTCGCCAAACATAGAGGCTTGCGGGTATAGCG
ATAGAGTACTGCAATTAACACTGGGAAACTCCACTATAACCACACAGGAGGCGGCTAATTCAGTAGTCGC
TTATGGGCGTTGGCCTGAATATCTGAGGGACAGCGAAGCCAATCCAGTGGACCAGCCGACAGAACCAGAC
GTCGCTGCATGCAGGTTTTATACGCTAGACACCGTGTCTTGGACGAAAGAGTCGCGAGGGTGGTGGTGGA
AGTTGCCTGATGCACTGAGGGACATGGGACTCTTTGGGCAAAATATGTACTACCACTACCTAGGTAGGTC
CGGGTACACCGTGCATGTACAGTGTAACGCCTCCAAATTCCACCAGGGGGCACTAGGGGTATTCGCCGTA
CCAGAGATGTGTCTGGCCGGGGATAGCAACACCACTACCATGCACACCAGCTATCAAAATGCCAATCCTG
GCGAGAAAGGAGGCACTTTCACGGGTACGTTCACTCCTGACAACAACCAGACATCACCTGCCCGCAGGTT
CTGCCCGGTGGATTACCTCCTTGGAAATGGCACGTTGTTGGGGAATGCCTTTGTGTTCCCGCACCAGATA
ATAAACCTACGGACCAACAACTGTGCTACACTGGTACTCCCTTACGTGAACTCCCTCTCGATAGATAGTA
TGGTAAAGCACAATAATTGGGGAATTGCAATATTACCATTGGCCCCATTAAATTTTGCTAGTGAGTCCTC
CCCAGAGATTCCAATCACCTTGACCATAGCCCCTATGTGCTGTGAGTTCAATGGATTAAGAAACATCACC
CTGCCACGCTTACAGGGCCTGCCGGTCATGAACACCCCTGGTAGCAATCAATATCTTACTGCAGACAACT
TCCAGTCACCGTGTGCGCTGCCTGAATTTGATGTGACCCCACCTATTGACATACCCGGTGAAGTAAAGAA
CATGATGGAATTGGCAGAAATCGACACCATGATTCCCTTTGACTTAAGTGCCACAAAAAAGAACACCATG
GAAATGTATAGGGTTCGGTTAAGTGACAAACCACATACAGACGATCCCATACTCTGCCTGTCACTCTCTC
CAGCTTCAGATCCTAGGTTGTCACATACTATGCTTGGAGAAATCCTAAATTACTACACACACTGGGCAGG
ATCCCTGAAGTTCACGTTTCTGTTCTGTGGATTCATGATGGCAACTGGCAAACTGTTGGTGTCATACGCG
CCTCCTGGAGCCGACCCACCAAAGAAGCGTAAGGAGGCGATGTTGGGAACACATGTGATCTGGGACATAG
GACTGCAGTCCTCATGTACTATGGTAGTGCCATGGATTAGCAACACCACGTATCGGCAAACCATAGATGA
TAGTTTCACCGAAGGCGGATACATCAGCGTCTTCTACCAAACTAGAATAGTCGTCCCTCTTTCGACACCC
AGAGAGATGGACATCCTTGGTTTTGTGTCAGCGTGTAATGACTTCAGCGTGCGCTTGTTGCGAGATACCA
CACATATAGAGCAAAAAGCGCTAGCACAGGGGTTAGGTCAGATGCTTGAAAGCATGATTGACAACACAGT
CCGTGAAACGGTGGGGGCGGCAACATCTAGAGACGCTCTCCCAAACACTGAAGCCAGTGGACCAACACAC
TCCAAGGAAATTCCGGCACTCACCGCAGTGGAAACTGGGGCCACAAATCCACTAGTCCCTTCTGATACAG
TGCAAACCAGACATGTTGTACAACATAGGTCAAGGTCAGAGTCTAGCATAGAGTCTTTCTTCGCGCGGGG
TGCATGCGTGACCATTATGACCGTGGATAACCCAGCTTCCACCACGAATAAGGATAAGCTATTTGCAGTG
TGGAAGATCACTTATAAAGATACTGTCCAGTTACGGAGGAAATTGGAGTTCTTCACCTATTCTAGATTTG
ATATGGAACTTACCTTTGTGGTTACTGCAAATTTCACTGAGACTAACAATGGGCATGCCTTAAATCAAGT
GTACCAAATTATGTACGTACCACCAGGCGCTCCAGTGCCCGAGAAATGGGACGACTACACATGGCAAACC
TCATCAAATCCATCAATCTTTTACACCTACGGAACAGCTCCAGCCCGGATCTCGGTACCGTATGTTGGTA
TTTCGAACGCCTATTCACACTTTTACGACGGTTTTTCCAAAGTACCACTGAAGGACCAGTCGGCAGCACT
AGGTGACTCCCTTTATGGTGCAGCATCTCTAAATGACTTCGGTATTTTGGCTGTTAGAGTAGTCAATGAT
CACAACCCGACCAAGGTCACCTCCAAAATCAGAGTGTATCTAAAACCCAAACACATCAGAGTCTGGTGCC
CGCGTCCACCGAGGGCAGTGGCGTACTACGGCCCTGGAGTGGATTACAAGGATGGTACGCTTACACCCCT
CTCCACCAAGGATCTGACCACATATGGATTCGGACACCAAAACAAAGCGGTGTACACTGCAGGTTACAAA
ATTTGCAACTACCACTTGGCCACTCAGGATGATTTGCAAAACGCAGTGAACGTCATGTGGAGTAGAGACC
TCTTAGTCACAGAATCAAGAGCCCAGGGCACCGATTCAATCGCAAGGTGCAATTGCAACGCAGGGGTGTA
CTACTGCGAGTCTAGAAGGAAATACTACCCAGTATCCTTCGTTGGCCCAACGTTCCAGTACATGGAGGCT
AATAACTATTACCCAGCTAGGTACCAGTCCCATATGCTCATTGGCCATGGATTCGCATCTCCAGGGGATT
GTGGTGGCATACTCAGATGTCACCACGGGGTGATAGGGATCATTACTGCTGGTGGCGAAGGGTTGGTTGC
ATTTTCAGACATTAGAGACTTGTATGCCTACGAAGAAGAAGCCATGGAACAAGGCATCACCAATTACATA
GAGTCACTTGGGGCCGCATTTGGAAGTGGATTTACTCAGCAGATTAGCGACAAAATAACAGAGTTGACCA
ATATGGTGACCAGTACCATCACTGAAAAGCTACTTAAGAACTTGATCAAGATCATATCCTCACTAGTTAT
TATAACTAGGAACTATGAAGACACCACAACAGTGCTCGCTACCCTGGCCCTTCTTGGGTGTGATGCTTCA
CCATGGCAGTGGCTTAGAAAGAAAGCATGCGATGTTCTGGAGATACCTTATGTCATCAAGCAAGGTGACA
GTTGGTTGAAGAAGTTTACTGAAGCATGCAACGCAGCTAAGGGACTGGAGTGGGTGTCAAACAAAATCTC
AAAATTCATTGATTGGCTCAAGGAGAAAATTATCCCACAAGCTAGAGATAAGTTGGAATTTGTAACAAAA
CTTAGACAACTAGAAATGCTGGAAAACCAAATCTCAACTATACACCAATCATGCCCTAGTCAGGAACACC
AGGAAATTCTATTCAATAATGTCAGATGGTTATCCATCCAGTCTAAGAGGTTTGCCCCTCTTTACGCAGT
GGAAGCCAAAAGAATACAGAAACTAGAGCATACTATTAACAACTACATACAGTTCAAGAGCAAACACCGT
ATTGAACCAGTATGTTTGCTAGTACATGGCAGCCCCGGAACAGGTAAATCTGTAGCAACCAACCTGATTG
CTAGAGCCATAGCTGAAAGAGAAAACACGTCCACGTACTCGCTACCCCCGGATCCATCACACTTCGACGG
ATACAAACAACAGGGAGTGGTGATTATGGACGACCTGAATCAAAACCCAGATGGTGCGGACATGAAGCTG
TTCTGTCAGATGGTATCAACAGTGGAGTTTATACCACCCATGGCATCCCTGGAGGAGAAAGGAATCCTGT
TTACTTCAAATTACGTTCTAGCATCCACAAACTCAAGCAGAATTTCCCCCCCCACTGTGGCACACAGTGA
TGCATTAGCCAGGCGCTTTGCGTTCGACATGGACATTCAGGTCATGAATGAGTATTCTAGAGATGGGAAA
TTGAACATGGCCATGGCTACTGAAATGTGTAAGAACTGTCACCAACCAGCAAACTTTAAGAGATGCTGTC
CTTTAGTGTGTGGTAAGGCAATTCAATTAATGGACAAATCTTCCAGAGTTAGATACAGTATTGACCAGAT
CACTACAATGATTATCAATGAGAGAAACAGAAGATCCAACATTGGCAATTGTATGGAGGCTTTGTTTCAA
GGACCACTCCAGTATAAAGACTTGAAAATTGACATCAAGACGAGTCCCCCTCCTGAATGTATCAATGACT
TGCTCCAAGCAGTTGACTCCCAGGAGGTGAGAGATTACTGTGAGAAGAAGGGTTGGATAGTCAACATCAC
CAGCCAGGTTCAAACAGAAAGGAACATCAACAGGGCAATGACAATTCTACAAGCGGTGACAACCTTCGCC
GCAGTGGCTGGAGTTGTCTATGTCATGTATAAACTGTTTGCTGGACACCAGGGAGCATACACTGGTTTAC
CAAACAAAAAACCCAACGTGCCCACCATTCGGACAGCAAAGGTACAAGGACCAGGGTTCGATTACGCAGT
GGCTATGGCTAAAAGAAACATTGTTACAGCAACTACTAGCAAGGGAGAGTTCACTATGTTAGGAGTCCAC
GACAACGTGGCTATTTTACCAACCCACGCTTCACCTGGTGAAAGCATTGTGATCGATGGCAAAGAAGTGG
AGATCTTGGATGCCAAAGCGCTCGAAGATCAAGCAGGAACCAATCTTGAAATCACTATAATCACTCTAAA
GAGAAATGAAAAGTTCAGAGACATTAGACCACATATACCTACTCAAATCACTGAGACAAATGATGGAGTC
TTGATCGTGAACACTAGCAAGTACCCCAATATGTATGTTCCTGTCGGTGCTGTGACTGAACAGGGATATC
TAAATCTCGGTGGGCGCCAAACTGCTCGTACTCTAATGTACAACTTTCCAACCAGAGCAGGACAGTGTGG
TGGAGTCATCACATGTACTGGGAAAGTCATCGGGATGCATGTTGGTGGGAACGGTTCACACGGGTTTGCA
GCGGCCCTGAAGCGATCATACTTCACTCAGAGTCAAGGTGAAATCCAGTGGATGAGACCTTCGAAGGAAG
TGGGATATCCAATCATAAATGCCCCGTCCAAAACCAAGCTTGAACCCAGTGCTTTCCACTATGTGTTTGA
AGGGGTGAAGGAACCAGCAGTCCTCACTAAAAACGATCCCAGGCTTAAGACAGACTTTGAGGAGGCAATT
TTCTCCAAGTACGTGGGTAACAAAATTACTGAAGTGGATGAGTACATGAAAGAGGCAGTAGACCACTATG
CTGGCCAGCTCATGTCACTAGACATCAACACAGAACAAATGTGCTTGGAGGATGCCATGTATGGCACTGA
TGGTCTAGAAGCACTTGATTTGTCCACCAGTGCTGGCTACCCTTATGTAGCAATGGGAAAGAAGAAGAGA
GACATCTTGAACAAACAAACCAGAGACACTAAGGAAATGCAAAAACTGCTCGACACATATGGAATCAACC
TCCCACTGGTGACTTATGTAAAGGATGAACTTAGATCCAAAACAAAGGTTGAGCAGGGGAAATCCAGATT
AATTGAAGCTTCTAGTTTGAATGACTCAGTGGCAATGAGAATGGCTTTTGGGAACCTATATGCTGCTTTT
CACAAAAACCCAGGAGTGATAACAGGTTCAGCAGTGGGGTGCGATCCAGATTTGTTTTGGAGCAAAATTC
CGGTATTGATGGAAGAGAAGCTGTTTGCTTTTGACTACACAGGGTATGATGCATCTCTCAGCCCTGCTTG
GTTCGAGGCACTAAAGATGGTGCTTGAGAAAATCGGATTCGGAGACAGAGTTGACTACATCGACTACCTA
AACCACTCACACCACCTGTACAAGAATAAAACATACTGTGTCAAGGGCGGTATGCCATCTGGCTGCTCAG
GCACTTCAATTTTTAACTCAATGATTAACAACTTGATTATCAGGACACTCTTACTGAAAACCTACAAGGG
CATAGATTTAGACCACCTAAAAATGATTGCCTATGGTGATGATGTAATTGCTTCCTACCCCCATGAAGTT
GACGCTAGTCTCCTAGCCCAATCAGGAAAAGACTATGGACTAACTATGACTCCAGCTGACAAATCAGCTA
CATTTGAAACAGTCACATGGGAGAATGTAACATTCTTGAAGAGATTCTTCAGGGCAGACGAGAAATACCC
ATTTCTTATTCATCCAGTAATGCCAATGAAGGAAATTCATGAATCAATTAGATGGACTAAAGATCCTAGG
AACACTCAGGATCACGTTCGCTCTCTGTGCCTTTTAGCTTGGCACAATGGCGAAGAAGAATATAACAAAT
TCCTAGCTAAAATCAGGAGTGTGCCAATTGGAAGAGCTTTATTGCTCCCAGAGTACTCAACATTGTACCG
CCGTTGGCTTGACTCATTTTAGTAACCCTACCTCAGTCGAATTGGATTGGGTCATACTGTTGTAGGGGTA
AATTTTTCTTTAATTCGGAG
Click to Show/Hide
|